$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

$bnet Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-K Financial Statement

#000107997321000987 Filed on September 29, 2021

Income Statement

Concept	2021 Q2	2021	2020 Q2
Revenue	$0.00		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$369.4K	$2.078M	$2.113M
YoY Change	-82.52%	-32.74%	367.46%
% of Gross Profit
Research & Development	$170.0K	$748.5K	$751.0K
YoY Change	-77.37%	-33.39%	466.19%
% of Gross Profit
Depreciation & Amortization	$210.00	$827.00	$210.00
YoY Change	0.0%	-33.73%	-38.24%
% of Gross Profit
Operating Expenses	$539.6K	$2.828M	$2.864M
YoY Change	-81.16%	-32.91%	389.6%
Operating Profit		-$2.828M
YoY Change		-32.91%
Interest Expense	-$112.5K	$657.9K	-$103.5K
YoY Change	8.75%	40.92%	-15.86%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$623.1K	$6.000K
YoY Change	-100.0%	84.11%
Pretax Income	-$652.1K	-$3.451M	-$2.839M
YoY Change	-77.03%	-24.21%	301.04%
Income Tax
% Of Pretax Income
Net Earnings	-$651.6K	-$3.451M	-$2.834M
YoY Change	-77.01%	-24.21%	300.65%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$17.42K	-$104.3K	-$93.76K
COMMON SHARES
Basic Shares Outstanding			30.15M
Diluted Shares Outstanding		33.07M

Balance Sheet

Concept	2021 Q2	2021	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.216M	$4.216M	$560.8K
YoY Change	651.8%	651.8%	1256.63%
Cash & Equivalents	$4.216M		$560.8K
Short-Term Investments
Other Short-Term Assets	$125.1K	$125.1K	$8.970K
YoY Change	1294.09%	1294.09%	-0.44%
Inventory
Prepaid Expenses	$124.0K		$7.965K
Receivables
Other Receivables
Total Short-Term Assets	$4.341M	$4.341M	$569.8K
YoY Change	661.92%	661.92%	1031.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$541.00	$540.00	$1.368K
YoY Change	-60.45%	-60.58%	-47.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$541.00	$540.00	$1.368K
YoY Change	-60.45%	-60.58%	-47.71%
TOTAL ASSETS
Total Short-Term Assets	$4.341M	$4.341M	$569.8K
Total Long-Term Assets	$541.00	$540.00	$1.368K
Total Assets	$4.342M	$4.342M	$571.2K
YoY Change	660.19%	660.19%	978.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$570.1K	$570.1K	$628.9K
YoY Change	-9.36%	-9.36%	-12.11%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.869M	$9.869M	$9.601M
YoY Change	2.79%	2.79%	3.2%
Total Short-Term Liabilities	$10.96M	$10.96M	$11.04M
YoY Change	-0.8%	-0.8%	1.07%
LONG-TERM LIABILITIES
Long-Term Debt	$4.793M	$4.793M	$4.616M
YoY Change	3.84%	3.84%	21.43%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$4.793M	$4.793M	$4.616M
YoY Change	3.84%	3.84%	21.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.96M	$10.96M	$11.04M
Total Long-Term Liabilities	$4.793M	$4.793M	$4.616M
Total Liabilities	$15.75M	$15.79M	$15.66M
YoY Change	0.57%	0.55%	6.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$132.3M		-$128.9M
YoY Change	2.68%		3.66%
Common Stock	$0.00		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$11.45M	-$11.45M	-$15.13M
YoY Change
Total Liabilities & Shareholders Equity	$4.342M	$4.342M	$571.2K
YoY Change	660.19%	660.19%	978.56%

Cashflow Statement

Concept	2021 Q2	2021	2020 Q2
OPERATING ACTIVITIES
Net Income	-$651.6K	-$3.451M	-$2.834M
YoY Change	-77.01%	-24.21%	300.65%
Depreciation, Depletion And Amortization	$210.00	$827.00	$210.00
YoY Change	0.0%	-33.73%	-38.24%
Cash From Operating Activities	-$505.6K	-$1.389M	-$213.1K
YoY Change	137.27%	43.78%	5.58%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities			$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$300.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.051M	5.045M	417.3K
YoY Change	631.18%	239.52%	343.98%
NET CHANGE
Cash From Operating Activities	-505.6K	-1.389M	-213.1K
Cash From Investing Activities			0.000
Cash From Financing Activities	3.051M	5.045M	417.3K
Net Change In Cash	2.546M	3.655M	204.2K
YoY Change	1146.56%	603.67%	-289.36%
FREE CASH FLOW
Cash From Operating Activities	-$505.6K	-$1.389M	-$213.1K
Capital Expenditures			$0.00
Free Cash Flow		-$1.389M	-$213.1K
YoY Change		43.78%	5.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	bnet	Effective Income Tax Rate Reconciliation Rtp Excess Business Interest Amount EffectiveIncomeTaxRateReconciliationRTPExcessBusinessInterestAmount	115000
CY2020	bnet	Effective Income Tax Rate Reconciliation Rtp Excess Business Interest Amount EffectiveIncomeTaxRateReconciliationRTPExcessBusinessInterestAmount	-103000
CY2020	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	1558015
CY2021	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	212645
CY2020	bnet	Adjustment To Additional Paid In Capital Modification Ofoptions AdjustmentToAdditionalPaidInCapitalModificationOfoptions	626058
CY2021	bnet	Adjustment To Additional Paid In Capital Modification Ofoptions AdjustmentToAdditionalPaidInCapitalModificationOfoptions	8775
CY2021	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	4065988
CY2021	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	4065988
CY2021	bnet	Common Stock Voting Rights Votes Per Share CommonStockVotingRightsVotesPerShare	1
CY2021Q2	bnet	Computers And Office Equipment Gross ComputersAndOfficeEquipmentGross	171485
CY2020Q2	bnet	Computers And Office Equipment Gross ComputersAndOfficeEquipmentGross	171485
CY2021	bnet	Conversion Of Debt And Liabilities ConversionOfDebtAndLiabilities	773811
CY2020	bnet	Conversion Of Debt And Liabilities ConversionOfDebtAndLiabilities	71658
CY2021	bnet	Conversion Of Deferred Compensation Into Note Payable Affiliate ConversionOfDeferredCompensationIntoNotePayableAffiliate
CY2020	bnet	Conversion Of Deferred Compensation Into Note Payable Affiliate ConversionOfDeferredCompensationIntoNotePayableAffiliate	636081
CY2021	bnet	Deferred Compensation Consecutive Trading Days DeferredCompensationConsecutiveTradingDays	P10D
CY2021	bnet	Deferred Compensation Conversion Days DeferredCompensationConversionDays	P5D
CY2018	bnet	Deferred Compensation Liability Amount Cancelled DeferredCompensationLiabilityAmountCancelled	2404000
CY2021Q2	bnet	Deferred Tax Assets Business Interest DeferredTaxAssetsBusinessInterest	264000
CY2020Q2	bnet	Deferred Tax Assets Business Interest DeferredTaxAssetsBusinessInterest	217000
CY2021	bnet	Defined Contribution Pension And Other Postretirement Plans Minimum Age DefinedContributionPensionAndOtherPostretirementPlansMinimumAge	P21Y
CY2021	bnet	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Allowance Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingAllowanceAmount	802000
CY2020	bnet	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Allowance Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingAllowanceAmount	71000
CY2013Q2	bnet	Extension Of Exercise Period Annual Payment Per Option Or Warrant ExtensionOfExercisePeriodAnnualPaymentPerOptionOrWarrant	0.05
CY2020	bnet	Gain Loss On Extinguishment Of Liabilities GainLossOnExtinguishmentOfLiabilities	122423
CY2021	bnet	Gain Loss On Extinguishment Of Liabilities GainLossOnExtinguishmentOfLiabilities
CY2021	bnet	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	8000
CY2020	bnet	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	9000
CY2021Q2	bnet	Interest Rate On Deferred Compensation InterestRateOnDeferredCompensation	0.04
CY2021Q2	bnet	Loans Payable Current Including Accrued Interest And Late Charges LoansPayableCurrentIncludingAccruedInterestAndLateCharges	9868495
CY2020Q2	bnet	Loans Payable Current Including Accrued Interest And Late Charges LoansPayableCurrentIncludingAccruedInterestAndLateCharges	9585883
CY2021	bnet	Payments Of Commissions On Exercise Of Warrants PaymentsOfCommissionsOnExerciseOfWarrants	3537
CY2020	bnet	Payments Of Commissions On Exercise Of Warrants PaymentsOfCommissionsOnExerciseOfWarrants
CY2021	bnet	Proceeds From The Sale Of Units ProceedsFromTheSaleOfUnits	1860000
CY2020	bnet	Proceeds From The Sale Of Units ProceedsFromTheSaleOfUnits	1584000
CY2020	bnet	Sale Of Units Value SaleOfUnitsValue	1584000
CY2021	bnet	Sale Of Units Value SaleOfUnitsValue	1860000
CY2021Q2	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309
CY2020Q2	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309
CY2021	bnet	Shares Issued For Accounts Payable And Accrued Expenses SharesIssuedForAccountsPayableAndAccruedExpenses
CY2020	bnet	Shares Issued For Accounts Payable And Accrued Expenses SharesIssuedForAccountsPayableAndAccruedExpenses	6750
CY2021	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions	97023
CY2020	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions
CY2021	bnet	Stock Issued During Period Shares Commission On Sale Of Units And Warrant Exercises StockIssuedDuringPeriodSharesCommissionOnSaleOfUnitsAndWarrantExercises	129364
CY2021	bnet	Stock Issued During Period Value Commission On Sale Of Units And Warrant Exercises StockIssuedDuringPeriodValueCommissionOnSaleOfUnitsAndWarrantExercises	-164537
CY2020	bnet	Stock Issued During Period Value Commissions On Sale Of Units StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits	147900
CY2021	bnet	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	3049490
CY2021	bnet	Warrants Issued For Unit Commissions WarrantsIssuedForUnitCommissions	16100
CY2020	bnet	Warrants Issued For Unit Commissions WarrantsIssuedForUnitCommissions	16509
CY2021	bnet	Weighted Average Exercise Price For Outstanding Warrants WeightedAverageExercisePriceForOutstandingWarrants	0.73
CY2021	bnet	Weighted Average Number Of Shares Issued During Period WeightedAverageNumberOfSharesIssuedDuringPeriod	2364136
CY2020	bnet	Weighted Average Number Of Shares Issued During Period WeightedAverageNumberOfSharesIssuedDuringPeriod	1666727
CY2021	bnet	Weighted Average Remaining Contractual Life For Outstanding Warrants WeightedAverageRemainingContractualLifeForOutstandingWarrants	P2Y292D
CY2021Q2	bnet	Working Capital WorkingCapital	-6614000
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Security12g Title Security12gTitle	Common Stock, No Par Value
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	570050
CY2020Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	628926
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2795084
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2794257
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	121399067
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	114266683
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	429200
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1017700
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2500
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2500
CY2021Q2	us-gaap	Assets Assets	4341911
CY2020Q2	us-gaap	Assets Assets	571161
CY2021Q2	us-gaap	Assets Current AssetsCurrent	4341370
CY2020Q2	us-gaap	Assets Current AssetsCurrent	569793
CY2021Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	401470
CY2020Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	401470
CY2021Q2	us-gaap	Cash Cash	4216321
CY2020Q2	us-gaap	Cash Cash	560828
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	560828
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41335
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4216321
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3655493
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	519493
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.75
CY2021Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	21900000
CY2021Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2020Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650
CY2020Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41315986
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31409005
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28068688
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40611677
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30704696
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27364379
CY2021Q2	us-gaap	Common Stock Value CommonStockValue
CY2020Q2	us-gaap	Common Stock Value CommonStockValue
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk:</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times <div style="display: inline; font-style: italic; font: inherit;"> may </div>exceed federally insured limits. The Company has <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced any losses on such accounts.</div></div></div></div></div></div></div></div></div></div>
CY2021Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	4793097
CY2020Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	4595841
CY2021Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	479208
CY2020Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	778217
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19724000
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19799000
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2020Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11784000
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11975000
CY2021Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1340000
CY2020Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1340000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	986000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1194000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5350000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5073000
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19724000
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19799000
CY2021Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000
CY2020Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000
CY2021	us-gaap	Depreciation Depreciation	827
CY2020	us-gaap	Depreciation Depreciation	1248
CY2021	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
CY2020	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	34800
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2078248
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3089689
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-75000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1144000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-724000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-955000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-126000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-166000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6516
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	95376
CY2021	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	396604
CY2020	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	520525
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	116084
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-40
CY2021	us-gaap	Interest Expense InterestExpense	657945
CY2020	us-gaap	Interest Expense InterestExpense	466891
CY2021	us-gaap	Interest Paid Net InterestPaidNet	28
CY2020	us-gaap	Interest Paid Net InterestPaidNet
CY2021Q2	us-gaap	Liabilities Liabilities	15748250
CY2020Q2	us-gaap	Liabilities Liabilities	15659119
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4341911
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	571161
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10955153
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11043359
CY2021Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2222670
CY2020Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2222670
CY2021Q2	us-gaap	Minority Interest MinorityInterest	39117
CY2020Q2	us-gaap	Minority Interest MinorityInterest	41902
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5044953
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1485900
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1389460
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-966407
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2785
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7506
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3447980
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4545735
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-623145
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-338468
CY2021	us-gaap	Open Tax Year OpenTaxYear	2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
CY2021	us-gaap	Operating Expenses OperatingExpenses	2827620
CY2020	us-gaap	Operating Expenses OperatingExpenses	4214773
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2827620
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-4214773
CY2021Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	47321000
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	694793
CY2020	us-gaap	Other Noncash Expense OtherNoncashExpense	502934
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6000
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	161000
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	147900
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	124049
CY2020Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7965
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	300000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2021	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt
CY2020	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	34800
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5209000
CY2020	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1584000
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	35000
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3049490
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2021	us-gaap	Profit Loss ProfitLoss	-3450765
CY2020	us-gaap	Profit Loss ProfitLoss	-4553241
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2795625
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2795625
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	541
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1368
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	20000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	748545
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1123836
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132339873
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128891893
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1126481
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2589134
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10471600
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.77
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	110000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2210000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	960000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.06
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20375
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6064335
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7411600
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9511600
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10471600
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.74
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.77
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.72
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.10
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.69
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	6064335
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y255D
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y36D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y182D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y255D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1017700
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	429200
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	960000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.06
CY2021Q2	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Current SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent	37400
CY2020Q2	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Current SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent	35400
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	71658
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	773811
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	16350
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	72000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	300000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-11445456
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-15129860
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11406339
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15087958
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14674598
CY2021Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2021Q2	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent
CY2020Q2	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	14933
CY2021Q2	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt
CY2020Q2	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	19919
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;">Use of estimates:</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In preparing the Company's consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div>
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33068832
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29031106
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33068832
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29031106

Files In Submission

Name	View Source	Status
0001079973-21-000987-index-headers.html	Edgar Link	pending
0001079973-21-000987-index.html	Edgar Link	pending
0001079973-21-000987.txt	Edgar Link	pending
0001079973-21-000987-xbrl.zip	Edgar Link	pending
bion_10k-063021.htm	Edgar Link	pending
bion_ex31z1.htm	Edgar Link	pending
bion_ex31z2.htm	Edgar Link	pending
bion_ex32z1.htm	Edgar Link	pending
bion_ex32z2.htm	Edgar Link	pending
bnet-20210630.xml	Edgar Link	completed
bnet-20210630.xsd	Edgar Link	pending
bnet-20210630_cal.xml	Edgar Link	unprocessable
bnet-20210630_def.xml	Edgar Link	unprocessable
bnet-20210630_lab.xml	Edgar Link	unprocessable
bnet-20210630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2021 Q2 Form 10-K Financial Statement

#000107997321000987 Filed on September 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2021 Q2 Form 10-K Financial Statement

#000107997321000987 Filed on September 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet